← Back

BSXBoston Scientific

$45.15-5.55%Real quote · delayedCardiovascular devices

🏛️ Company factsSEC filings + FINRA official data

Annual revenue $20.1B · latest quarter up 7.5% YoY · short activity below its recent average — bears covering.

FY revenue

$20.1B

2025-12

Latest Q YoY

+7.5%

Gross margin

69%

Diluted EPS

$1.96

Short volume

37.8%

20d avg 49.4% · shorts covering

🐋 5%+ ownership filings (last 180d)

The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.

2026-08-06passive (13G)FMR LLC
2026-04-29passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
2026-03-26passive (13G)VANGUARD GROUP INC

🎯 Market expectations

Expectation reliability High · 80/100

Nasdaq analyst consensus · the pre-news baseline

Next quarter (Sep 2026) consensus$0.80Estimate range $0.79 ~ $0.81 · 8 analysts

History: actual vs consensusavg +3%

Jun 2026$0.86 vs $0.83+3.61%
Mar 2026$0.80 vs $0.800%
Dec 2025$0.80 vs $0.78+2.56%
Sep 2025$0.75 vs $0.71+5.63%

The takeaway

This company habitually beats by +3% — the next report has to clear that bar to count as good news.

Analyst estimates, not our forecast · not investment advice

🧭 -5.5% today with no fresh news · why?

📊 Market-0.1%S&P -0.4% × beta 0.3
💸 Money flowMFI 29 · net outflow · volume 0.9× average
🧩 PeersMDT -1.8%ISRG -4.2%EW -3.1%3 peers moved the same way today, averaging -3% — this is a sector move, not a single-stock event.

Educational decomposition · not investment advice

What's moving this stock lately

0 direct · 1 2nd-order · 0 thematic

Ranked by impact strength · strength = estimated move × freshness decay (shorter-lived effects decay faster)

#1▼0.45%2nd-orderLate Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half12d ago
A decline in catheterization procedure volumes could indirectly slow demand growth for Boston Scientific's coronary intervention devices.
Impact chain →
Also named: HTFL · SHL.DE · GEHC · PHG · ABT · MDT

🕰️ Price × news · engine report card

Drag to pan, scroll to zoom · real daily bars and volume

The 4 engine calls on this chart (hit / miss / pending) are Pro — price and volume only for now▂ volume

📜 Call history (newest first

🔒 Pro only

4 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view

🔒 Pro only

Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.